Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lifeward Ltd (LFWD)

Lifeward Ltd (LFWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,903
  • Shares Outstanding, K 1,528
  • Annual Sales, $ 22,030 K
  • Annual Income, $ -19,910 K
  • EBIT $ -20 M
  • EBITDA $ -19 M
  • 60-Month Beta 0.12
  • Price/Sales 0.47
  • Price/Cash Flow N/A
  • Price/Book 1.24

Options Overview Details

View History
  • Implied Volatility 0.00% (unch)
  • Historical Volatility 117.93%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Expected Move (DTE 0) 0.00 (0.00%)
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A
  • Expected Range 6.40 to 6.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.34
  • Number of Estimates 1
  • High Estimate -0.34
  • Low Estimate -0.34
  • Prior Year -5.52
  • Growth Rate Est. (year over year) +93.84%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.14 +56.52%
on 02/24/26
7.57 -14.40%
on 03/17/26
+1.89 (+41.03%)
since 02/23/26
3-Month
4.14 +56.52%
on 02/24/26
8.96 -27.70%
on 01/20/26
-1.32 (-16.92%)
since 12/23/25
52-Week
4.14 +56.52%
on 02/24/26
23.04 -71.88%
on 03/27/25
-14.16 (-68.60%)
since 03/21/25

Most Recent Stories

More News
Lifeward: Q4 Earnings Snapshot

Lifeward: Q4 Earnings Snapshot

LFWD : 6.05 (-6.64%)
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results

Advancing t ransformation into a d iversified b iomedical i nnovation c ompany with a c lear p ath to c ash f low p ositiv e Oramed s trategic t ransaction ...

LFWD : 6.05 (-6.64%)
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company

Position s Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed’s POD™ oral delivery technology expands Lifeward into biotech...

ORMP : 3.53 (-0.56%)
LFWD : 6.05 (-6.64%)
Lifeward Regains Compliance with Nasdaq Minimum Bid Price Requirement

HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 11, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform...

LFWD : 6.05 (-6.64%)
Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to...

LFWD : 6.05 (-6.64%)
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton

Clinic  d ays offered at Shirley Ryan AbilityLab, the #1 ranked rehabilitation hospital for 35 consecutive years , with the goal of a ccelerat ing p ersonal e xoskeleton...

LFWD : 6.05 (-6.64%)
Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke Survivors

IP and technology acquisition is expected to be highly accretive and to advance Lifeward’s position as a diversified biomedical innovation company Will Expand Lifeward’s portfolio...

LFWD : 6.05 (-6.64%)
Lifeward Announces Reverse Share Split

HUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed...

LFWD : 6.05 (-6.64%)
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers

Aetna joins Humana and United Healthcare in providing Medicare Advantage coverage for beneficiaries who meet medical necessity criteria for the ReWalk Personal Exoskeleton Together, these three national...

LFWD : 6.05 (-6.64%)
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company

Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential Up to $47 million strategic investment from Oramed and another investor is intended...

ORMP : 3.53 (-0.56%)
LFWD : 6.05 (-6.64%)

Business Summary

Lifeward designs, develops and commercializes life-changing solutions which span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. The company's portfolio features products including...

See More

Key Turning Points

3rd Resistance Point 7.65
2nd Resistance Point 7.27
1st Resistance Point 6.87
Last Price 6.05
1st Support Level 6.09
2nd Support Level 5.71
3rd Support Level 5.31

See More

52-Week High 23.04
Fibonacci 61.8% 15.82
Fibonacci 50% 13.59
Fibonacci 38.2% 11.36
Last Price 6.05
52-Week Low 4.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.